Director, Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology
Human and Translational Immunology Program
The mission of the Human and Translational Immunology (HTI) Program at the Yale School of Medicine is to accelerate the application of new developments in the field of immunology to the treatment of human diseases. With its administrative base within the Department of Immunobiology and its core laboratories housed in the Amistad building and the George Street Facility, the HTI program is open to all members of the Yale School of Medicine faculty with an interest in human immunology and the contributions of immunology to disease. The HTI faculty study the immunologic aspects of a very broad range of human diseases, encompassing investigations in the fields of cancer and cancer therapeutics, transplantation of solid organs and stem cells; autoimmune diseases including endocrine diseases such as Type 1 diabetes, rheumatologic diseases including rheumatoid arthritis and systemic lupus erythematosis; pulmonary diseases including asthma and chronic obstructive pulmonary disease; neurologic diseases such as multiple sclerosis; gastrointestinal diseases such as Crohn's disease, celiac sprue, and ulcerative colitis; and many others. HTI programs offer investigators the opportunity to interact with other clinical and basic scientists to develop investigations in the treatment of human disease, and access to resources to support this work. Providing resources to develop novel therapies that are in the early stages (Phase I/II) of development are a top priority of HTI, which will assist in preparing applications to the Immune Tolerance Network, the FOCIS Centers of Excellence, Trialnet and other multi-institutional organizations.
The HTI seminar series highlights studies of human disease and features nationally recognized internal and outside speakers. A training grant to develop the careers of new investigators with expertise in human translational immunology and support the work of these individuals in the laboratories of the HTI faculty is planned.
HTI membership is open to Yale faculty interested in translational immunology. Approval for membership is given by the HTI steering committee.
HTI Leadership
HTI Members
Professor, Obstetrics, Gynecology & Reproductive Sciences; Director, Division of Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences
Associate Professor of Medicine; Director, Fellowship Program, Digestive Diseases
Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy, & Immunology; Rheumatologist in Chief, Rheumatology
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology); Co-Leader, Cancer Immunology, Yale Cancer Center
Associate Professor of Medicine (Pulmonary); Director, Newington VA Pulmonary Clinic, Medicine; Co-Director, Yale Center for Asthma and Airway Diseases
Paul B. Beeson Professor of Medicine (Rheumatology) and Professor of Immunobiology; Paul B. Beeson Professor of Medicine; Program Director, Investigative Medicine
Eugene Higgins Professor of Immunobiology and Professor of Cell Biology
Associate Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine) and of Microbial Pathogenesis; Director, Center for Pulmonary Infection Research and Treatment (CPIRT)
Associate Professor of Laboratory Medicine, Immunobiology, Immunology; Associate Chair of Research, Laboratory Medicine; Assistant Director of Clinical Pathology Residency Program
Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases) and Professor of Epidemiology (Microbial Diseases) and of Microbial Pathogenesis; Section Chief, Infectious Diseases
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Assistant Professor of Laboratory Medicine and Immunobiology
Professor of Dermatology; Dermatology; Director, Residency Program; Vice Chair; Director, T32 Research Fellowship Program
Associate Professor of Immunobiology; Director, In Vivo Imaging Facility; Director, Flow Cytometry Facility
Human and Translational Immunology
Sep 202128Tuesday
Yale Only 4:00 PM5:00 PMCarola Vinuesa, LMS, PhD
Latest News
- August 19, 2021
Preventing Type 1 Diabetes: Q&A With Kevan Herold, MD
- July 29, 2021Source: YaleNews
Rare Disorder Offers Roadmap for Understanding Roots of Inflammatory Disease
- May 27, 2021Source: YaleNews
Rogue Antibodies Wreak Havoc in Severe COVID-19 Cases
- April 22, 2021Source: YaleNews
Immune System, not COVID Virus, May Pose Greatest Risk to Pregnant Women